MRTNZ

MRTNZ Investment Office · S&P 500 · The 360 Vantage

ALB · NYSE

Albemarle Corporation

Industrials · Major Chemicals

Reference price$113.16As of Jul 28, 2026
Market capitalization$13.35B
52-week range$64.95–$221.00
S&P 500 portfolio weight0.02%
Data qualitycomplete

Street view

Analyst targets

Published sell-side aggregation—not an MRTNZ forecast.

Low$155.00+37.0% vs. reference
Average$206.59+82.6% vs. reference
High$264.00+133.3% vs. reference
10 Buy7 Hold0 Sell

Forward calendar

Current earnings expectations

Consensus may change until the company reports.

Expected reportAug 5, 2026Jun 2026
Consensus EPS$3.396 estimates
Expected range$2.98–$4.24Low to high EPS
Dec 2026$12.86Street EPS consensus
Dec 2027$12.52Street EPS consensus
Dec 2028$14.87Street EPS consensus

Reported results

Annual financial snapshot

Fiscal period ended Dec 31, 2025.

MetricCurrentPrior
Revenue-4.4% YoY$5.14B$5.38B
Operating income($0.37B)($1.78B)
Net income($0.51B)($1.18B)
Operating cash flow$1.28B$0.69B
Capital expenditures($0.59B)($1.68B)

Current context

Related news

Company-linked articles surfaced by Nasdaq.

BNK Invest

Daily Dividend Report: C,ALB,ROL,NSC,APD,MCK

Zacks

BASF Expands Specialty Emollients Capacity With New Dusseldorf Plant

Zacks

NGVT's Evotherm P35 Gets German Approval for Warm-Mix Asphalt Use

Evidence

Sources & method

Nasdaq quote →Nasdaq summary →Earnings forecast →Annual financials →Official S&P 500-tracking holdings →

Facts, estimates, and scenarios are kept separate. Analyst targets and EPS expectations are third-party estimates, not MRTNZ forecasts. Index weight uses the official IVV portfolio as the denominator. Illustrative research, not investment advice.